5 news items
Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
ARVN
17 Jun 24
@arvinas.com Media Contact:Kathleen Murphy, Arvinas Communications
Analyst Ratings For Arvinas
ARVN
17 May 24
' to 'Underperform'. These ratings communicate expectations for the relative performance of Arvinas compared to the broader market.
Price Targets
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCEĀ®)
ARVN
PFE
16 May 24
premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed
- Prev
- 1
- Next